Glatthaar BE, Barbarsah GR, Noyes BE, Banaszak LJ, Bradshaw RA
The primary efficacy endpoints, measured at 24 weeks, were MASH resolution without worsening of fibrosis, or fibrosis improvement without worsening of MASH
Peptide AOD 9604 therapy has been gaining traction in the medical and wellness communities for it use as a support for fat loss, improving metabolic function, and activating recovery without most of the risks of other hormonal agents
Additionally, glutathione supports overall skin health by boosting the immune system and enhancing cellular repair mechanisms, making it a valuable component in anti-aging and skin-whitening treatments
The medication helps manage obesity while it is being taken, but lasting success depends on sustainable changes to nutrition, physical activity, and behaviour